Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
Clinical trial NCT03001076 · COMPLETED
Trial details
- NCT number
- NCT03001076
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2018-01-11
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.